ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Seven Softgel Myths: Are You Missing Your Softgel Opportunity?

  Softgels are a popular dose format among consumers, thanks to their high swallowability and quick onset of action, yet pharmaceutical developers may not even consider them. Why the disconnect?

• Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

• Hospital To Home: What It Means For Patients, Providers And Medical Devices

  Healthcare is shifting homeward. With telehealth, connected devices, and user-friendly design, patients and caregivers now deliver hospital-level care safely and effectively outside clinical settings.

• Nanoformed API: A Superior Alternative To Solid Dispersions

  Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

• Containment Solutions To Help Emerging Biologic Companies

  Set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.

• Advancements In GLP-1 Analog Formulation: Overcoming Challenges

  Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

• Formulation Development For Injectables

  A uniquely modified cyclodextrin is emerging as a versatile and indispensable tool for development. Explore how the right formulation approach can enhance drug delivery and improve patient outcomes.

• Best Practices For Ensuring Quality In Biologic Products

  New biologic therapies have new challenges in their packaging and delivery systems because of their complexities, higher stability risks, and larger sizes. 

• Implementing Medium And High-Volume Drug Handling And Packaging Programs

  Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.

• Gaps In Reconstitution Process Filled By Water-For-Injection Syringe

  The recent rise in biopharmaceutical drugs has sparked renewed interest in lyophilization as a way to bring injectable biologics and other drugs to market more quickly.